mTOR inhibitor, such as rapamycin, could reduce NF‐λB activity, suppress inflammatory SASPs at the translational level, and constrain the tumor‐prompting effect of senescent bystander fibroblasts.52, 188. This evidence concerns the gene MTOR and neoplasm.